Back to News
Market Impact: 0.18
PHIL Partners with Biotechnology Leader, Evolved Health, to Launch New Day™ Skin Spray Direct-to-Patient Program
Source: Business Wire
Healthcare & BiotechProduct LaunchesCompany Fundamentals
PHIL and Evolved Health are partnering to launch New Day™ Skin Spray, a direct-to-patient delivery of a novel atopic dermatitis prescription. The rollout is focused on improving access by shipping the therapy directly to patients, which is a modest positive for commercialization prospects.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- ‘I told you so’: China’s chip sector is making breakthroughs—and U.S. export controls are the reasons why
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- The IPO drought is driving private equity-owned companies to the debt market to pay investors
- Hybe shares jump 10% as K-pop sensation BTS' tour lifts earnings hopes
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’
- EU Seeks New Trade Powers to Cut Trade Deficit
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Vendor Landscape for Institutional Investment Teams
- AllMind Fixed Income Compass for October 2025: Navigating Policy Divergence and Political Risk